Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

TB Elimination: Treatment of Latent Tuberculosis Infection: Maximizing Adherence

Information Sheet
TB Elimination: Treatment of Latent Tuberculosis Infection: Maximizing Adherence

This information sheet discusses the need for individuals with latent TB infection (LTBI) to get treatment and prevent the progression of LTBI to TB disease. It emphasizes the importance of the health care provider communicating the value of LTBI treatment and of identifying barriers to adherence. The information sheet also lists strategies for maximizing adherence including collaborating with community agencies and partnering with local health departmetns and community based organizations that can provide needed resources.

Topic:

TB Prevention

Country of Origin:

United States

View Webpage

Related Materials

Treatment of Latent Tuberculosis Infection: Maximizing Adherence

This fact sheet provides strategies for health care providers to use to maximize adherence by their patients for the treatment of latent tuberculosis infection (LTBI).

Fact Sheet

TB Elimination: Treatment Options for Latent Tuberculosis Infection

This information sheet discusses treatment for individuals with latent tuberculosis infection (LTBI), with the purpose of this treatment being the reduction of the risk that the infection will progress to TB disease. It explains how the health care provider determines whether the individual with a positive tuberculin skin test (TST) or blood test result is a candidate for treatment of LTBI and how the most effective regimen is chosen; presents LTBI treatment regimens; and describes monitoring during treatment, drug-drug interactions, particularly for HIV-infected patients, and side effects.

Information Sheet

Treatment for Latent Tuberculosis (TB) Infection: Rifampin

This handout contains information for patients that are prescribed the 4-month daily regimen of rifampin (4R) for the treatment of latent TB infection. The handout includes space to record the patient's doctor/clinic contact information. 

Brochure

Global resources for the prevention,
management, and elimination of TB.